129 related articles for article (PubMed ID: 34257711)
1. RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1.
Zhou L; Xie X
Exp Ther Med; 2021 Aug; 22(2):898. PubMed ID: 34257711
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.
Ramalingam S; Ramamoorthy P; Subramaniam D; Anant S
Immunogastroenterology; 2012; 1(1):27-33. PubMed ID: 23795348
[TBL] [Abstract][Full Text] [Related]
3. Erratum: RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1.
Zhou L; Xie X
Exp Ther Med; 2022 Mar; 23(3):245. PubMed ID: 35222722
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
5. CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.
Wang L; Liu Z; Liu L; Guo C; Jiao D; Li L; Zhao J; Han X; Sun Y
J Cell Mol Med; 2021 Aug; 25(15):7559-7574. PubMed ID: 34288370
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.
Liao C; Chen W; Wang J
World Neurosurg; 2019 Jan; 121():e519-e527. PubMed ID: 30268547
[TBL] [Abstract][Full Text] [Related]
7. The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B.
Guo Q; Wu Y; Guo X; Cao L; Xu F; Zhao H; Zhu J; Wen H; Ju X; Wu X
Mol Ther Nucleic Acids; 2021 Mar; 23():169-184. PubMed ID: 33335801
[TBL] [Abstract][Full Text] [Related]
8. LncRNA RHPN1-AS1 promotes the progression of nasopharyngeal carcinoma by targeting CELF2 expression.
Zhao Y; Zhou H; Dong W
Exp Mol Pathol; 2021 Oct; 122():104671. PubMed ID: 34358519
[TBL] [Abstract][Full Text] [Related]
9. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
Wu JZ; Jiang N; Lin JM; Liu X
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression.
Wen X; Chen Y; Fang X
Exp Ther Med; 2021 Sep; 22(3):1006. PubMed ID: 34345288
[TBL] [Abstract][Full Text] [Related]
12. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.
Wu L; Zhang D; Zhou L; Pei Y; Zhuang Y; Cui W; Chen J
EBioMedicine; 2019 Mar; 41():384-394. PubMed ID: 30803933
[TBL] [Abstract][Full Text] [Related]
13. Role of the TPX2/NCOA5 axis in regulating proliferation, migration, invasion and angiogenesis of breast cancer cells.
Wang T; Zhang F; Zhang P
Exp Ther Med; 2023 Jun; 25(6):304. PubMed ID: 37229326
[TBL] [Abstract][Full Text] [Related]
14. [CD137-CD137L signaling promotes angiogenesis in atherosclerosis plaque of mice through activating nuclear factor of activated T cells c1].
Weng JY; Yan JC; Chen Y; Wang ZQ; Wang CP; Shao C
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Dec; 44(12):1040-1046. PubMed ID: 28056236
[No Abstract] [Full Text] [Related]
15. Proliferation, apoptosis and invasion of human lung cancer cells are associated with NFATc1.
Ren F; Zhu K; Wang Y; Zhou F; Pang S; Chen L
Exp Ther Med; 2023 Jan; 25(1):49. PubMed ID: 36588811
[TBL] [Abstract][Full Text] [Related]
16. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
17. Pleotropic role of RNA binding protein CELF2 in autophagy induction.
New J; Subramaniam D; Ramalingam S; Enders J; Sayed AAA; Ponnurangam S; Standing D; Ramamoorthy P; O'Neil M; Dixon DA; Saha S; Umar S; Gunewardena S; Jensen RA; Thomas SM; Anant S
Mol Carcinog; 2019 Aug; 58(8):1400-1409. PubMed ID: 31020708
[TBL] [Abstract][Full Text] [Related]
18. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J
Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762
[TBL] [Abstract][Full Text] [Related]
19. Induced transcription and stability of CELF2 mRNA drives widespread alternative splicing during T-cell signaling.
Mallory MJ; Allon SJ; Qiu J; Gazzara MR; Tapescu I; Martinez NM; Fu XD; Lynch KW
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2139-48. PubMed ID: 25870297
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171.
Wang W; Cheng X; Zhu J
Oncol Lett; 2021 Mar; 21(3):193. PubMed ID: 33574932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
